» Articles » PMID: 27142714

Timing of Retinal Neuronal and Axonal Loss in MS: a Longitudinal OCT Study

Overview
Journal J Neurol
Specialty Neurology
Date 2016 May 5
PMID 27142714
Citations 65
Authors
Affiliations
Soon will be listed here.
Abstract

The objective of the study was to investigate the timing of central nervous system tissue atrophy in MS by evaluating longitudinal retinal volume changes in a broadly representative cohort with disease duration across the entire arc of disease. In this longitudinal study, 135 patients with MS and 16 healthy reference subjects underwent spectral-domain optical coherence tomography (OCT) at baseline and 2 years later. Following OCT quality control, automated segmentation of the peripapillary retinal nerve fiber layer (pRNFL), macular ganglion cell-inner plexiform layer (mGCIPL) and macular inner nuclear layer (mINL) was performed. Generalized estimation equations were used to analyze longitudinal changes and associations with disease duration and clinical measures. Participants had a median disease duration at baseline of 16.4 years (range 0.1-45.4). Nearly half (44 %) of the MS patients had previously experienced MS-related optic neuritis (MSON) more than 6 months prior. The MS patients demonstrated a significant decrease over 2 years of the pRNFL (-1.1 µm, 95 % CI 1.4-0.7, p < 0.001) and mGCIPL (-1.1 µm, 95 % CI -1.4 to -0.8, p < 0.001). This thinning was most pronounced early in the course of disease. These findings were irrespective of previous episodes of MSON. No consistent pattern of change was observed for the mINL (-0.03 µm, 95 % CI -0.2 to 0.2, p = 0.795). This longitudinal study demonstrated that injury of the innermost retinal layers is found in MS and that this damage occurs most rapidly during the early stages of disease. The attenuation of atrophy with longer disease duration is suggestive of a plateau effect. These findings emphasize the importance of early intervention to prevent such injury.

Citing Articles

Effect of Different Treatments on Retinal Thickness Changes in Patients With Multiple Sclerosis: A Review.

Adibi A, Adibi I, Javidan M CNS Neurosci Ther. 2025; 31(1):e70225.

PMID: 39853938 PMC: 11759887. DOI: 10.1111/cns.70225.


Paramagnetic rim lesions are associated with inner retinal layer thinning and progression independent of relapse activity in multiple sclerosis.

Krajnc N, Hofer L, Fottinger F, Dal-Bianco A, Leutmezer F, Kornek B Eur J Neurol. 2024; 32(1):e16529.

PMID: 39529542 PMC: 11622274. DOI: 10.1111/ene.16529.


Longitudinal evaluation of retinal neuroaxonal loss in epilepsy using optical coherence tomography.

Stauner L, Bao H, Delazer L, Kirsch I, Christmann T, Noachtar S Epilepsia. 2024; 65(12):3644-3654.

PMID: 39380535 PMC: 11647422. DOI: 10.1111/epi.18139.


Early reduction of retinal thickness predicts physical and cognitive disability in newly diagnosed multiple sclerosis patients: results from a cross-sectional study.

Toscano S, Chisari C, Biondi A, Patti F Neurol Sci. 2024; 45(11):5385-5394.

PMID: 38951431 PMC: 11470849. DOI: 10.1007/s10072-024-07664-9.


Individual Prognostication of Disease Activity and Disability Worsening in Multiple Sclerosis With Retinal Layer Thickness Scores.

Lin T, Motamedi S, Asseyer S, Chien C, Saidha S, Calabresi P Neurol Neuroimmunol Neuroinflamm. 2024; 11(5):e200269.

PMID: 38941572 PMC: 11214150. DOI: 10.1212/NXI.0000000000200269.


References
1.
Trip S, Schlottmann P, Jones S, Altmann D, Garway-Heath D, Thompson A . Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Ann Neurol. 2005; 58(3):383-91. DOI: 10.1002/ana.20575. View

2.
Dalton C, Chard D, Davies G, Miszkiel K, Altmann D, Fernando K . Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. Brain. 2004; 127(Pt 5):1101-7. DOI: 10.1093/brain/awh126. View

3.
Tatrai E, Simo M, Iljicsov A, Nemeth J, DeBuc D, Somfai G . In vivo evaluation of retinal neurodegeneration in patients with multiple sclerosis. PLoS One. 2012; 7(1):e30922. PMC: 3266905. DOI: 10.1371/journal.pone.0030922. View

4.
De Stefano N, Matthews P, Filippi M, Agosta F, De Luca M, Bartolozzi M . Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology. 2003; 60(7):1157-62. DOI: 10.1212/01.wnl.0000055926.69643.03. View

5.
Fisher E, Lee J, Nakamura K, Rudick R . Gray matter atrophy in multiple sclerosis: a longitudinal study. Ann Neurol. 2008; 64(3):255-65. DOI: 10.1002/ana.21436. View